Renalytix Ai (Reg S) (RENX)

Sector:

Health Care

 250.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 328.00
  • 52 Week Low: 90.00
  • Currency: UK Pounds
  • Shares Issued: 59.42m
  • Volume: 21,134
  • Market Cap: £148.54m
  • RiskGrade: 113
  • Beta: 0.25

RENX Overview

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 6.8  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

RENX Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-18 n/a (0.42) (1.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-19 n/a (6.52) (15.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

RENX Company Announcements

Partnership with CDPHP on KidneyIntelX 17-Oct-2019 07:00 RNS
Board appointment 14-Oct-2019 07:00 RNS
US CPT® reimbursement code effective 01-Oct-2019 07:00 RNS

Latest RENX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

RENX Market Data

Currency UK Pounds
Share Price 250.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 328.00
52 Week Low 90.00
Volume 21,134
Shares Issued 59.42m
Market Cap £148.54m
Beta 0.25
RiskGrade 113

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
28.33% below the market average28.33% below the market average28.33% below the market average28.33% below the market average28.33% below the market average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average
Price Trend
76.46% above the market average76.46% above the market average76.46% above the market average76.46% above the market average76.46% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for 13-Nov-2019

Time Volume / Share Price
13:09 2,500 @ 241.16p
11:34 1,534 @ 241.16p
11:26 5,691 @ 250.00p
11:26 2,817 @ 250.00p
11:26 10,000 @ 250.00p

RENX Key Personnel

CEO James Renwick McCullough
CFO James Sterling
COO Sally Bowden

Top of Page